Related Experiment Videos
Nephelometric detection of circulating immune complexes using monoclonal rheumatoid factor
Journal of Immunological Methods
|January 1, 1979
Summary
A new nephelometric assay using human monoclonal rheumatoid factor (mRhF) effectively detects immune complexes (IC) in serum, offering a rapid and simple method. This assay complements existing techniques, particularly for IC in antigen excess, aiding in disease diagnosis.
Area of Science:
- Immunology
- Analytical Chemistry
Background:
- Immune complexes (IC) are crucial biomarkers in various autoimmune diseases and cancers.
- Accurate detection of IC is vital for diagnosis and monitoring disease progression.
- Existing methods like C1q radioimmunoassay (RIA) have limitations in sensitivity and specificity depending on IC composition.
Purpose of the Study:
- To develop and standardize a novel nephelometric assay for quantifying serum immune complexes (IC).
- To evaluate the performance of this new assay against the established C1q radioimmunoassay (C1q RIA).
- To assess the utility of the mRhF nephelometric assay in patient populations with rheumatoid arthritis, systemic lupus erythematosus, and melanoma.
Main Methods:
- Development of a nephelometric technique utilizing human monoclonal rheumatoid factor (mRhF) specific for complexed IgG.
- Standardization using heat-aggregated human IgG and in vitro-formed IC (ovalbumin/rabbit anti-ovalbumin).
- Comparative analysis with [125I]Clq radioimmunoassay (C1q RIA) using patient sera and varying antigen-antibody ratios.
Main Results:
- The mRhF nephelometric assay demonstrated similar lower detection limits to C1q RIA for certain IC types.
- The nephelometric method showed higher sensitivity for IC formed in antigen excess, especially with polyethylene glycol (PEG) enhancement.
- C1q RIA was more sensitive for IC in antibody excess but failed to detect IC in antigen excess.
- The mRhF assay detected fewer IC in rheumatoid arthritis and systemic lupus erythematosus patients compared to C1q RIA, suggesting different IC compositions.
- The mRhF assay detected more IC in melanoma patients, potentially indicating IC in antigen excess.
Conclusions:
- The mRhF nephelometric assay is a rapid, simple, and effective method for detecting serum immune complexes (IC).
- This assay complements the C1q RIA, offering enhanced sensitivity for IC in antigen excess.
- The mRhF nephelometric technique provides valuable diagnostic information, particularly for conditions like melanoma, and can be extended to detect other IC types.